Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CYP4F3 |
| Upstream (Parents) |
|---|
| (<<) PROC → CYP4F3 |
| (<<) CYP4F2 → CYP4F3 |
| (<<) ECHDC2 → CYP4F3 |
| Downstream (Children) |
|---|
| CYP4F3 → CNGA1 (>>) |
| CYP4F3 → CFB (>>) |
| CYP4F3 → CYP4F12 (>>) |
| CYP4F3 → UGT2B17 (>>) |
| CYP4F3 → CYP4F2///CYP4F3 (>>) |
| CYP4F3 → CYP4F2 (>>) |
| CYP4F3 → MYRIP (>>) |
| CYP4F3 → MICALL1 (>>) |
| CYP4F3 → NKX3-2 (>>) |
| CYP4F3 → ECHDC2 (>>) |
